How to Prepare 2 g IV Magnesium Sulfate for Acute COPD Exacerbation
Dilute 4 mL of 50% magnesium sulfate solution (containing 2 g) in 100-250 mL of either 5% dextrose or 0.9% normal saline, creating a concentration of 20% or less, and infuse intravenously over 20-30 minutes.
Preparation Steps
Standard Dilution Protocol
Based on FDA labeling 1, magnesium sulfate 50% solution must be diluted to a concentration of 20% or less before IV infusion:
- Draw up 4 mL of 50% magnesium sulfate solution (500 mg/mL) = 2 g total dose
- Add to 100-250 mL of compatible diluent:
- 5% Dextrose Injection, USP, OR
- 0.9% Sodium Chloride Injection, USP
- This creates a final concentration of approximately 8-20 mg/mL (well below the 20% maximum)
Infusion Rate
- Administer over 20-30 minutes 1, 2
- The general FDA guideline states IV injection should not exceed 150 mg/minute (1.5 mL of 10% solution), which translates to approximately 20-30 minutes for a 2 g dose
- Research protocols consistently used 20-30 minute infusion times 3, 2
Clinical Context
While major COPD guidelines 4, 5 do not specifically recommend magnesium sulfate as standard therapy for acute exacerbations, emerging evidence suggests potential benefit. A 2022 Cochrane review 6 found that IV magnesium may reduce hospital admissions (OR 0.45), shorten hospital stay by 2.7 days, and improve dyspnea scores, though the evidence quality is low to very low.
Important Safety Considerations
Monitor closely during infusion 1:
- Patellar reflex (knee jerk) - diminishes at magnesium levels >4 mEq/L, absent at 10 mEq/L
- Respiratory rate - maintain ≥16 breaths/minute
- Urine output - should be ≥100 mL in 4 hours preceding dose
- Serum magnesium levels - therapeutic range 3-6 mg/100 mL (2.5-5 mEq/L)
Contraindications and Cautions
- Renal impairment: Use with extreme caution; magnesium is eliminated solely by kidneys 1
- Digitalized patients: Administer with extreme caution due to potential cardiac conduction changes 1
- Have calcium gluconate immediately available as antidote for magnesium toxicity 1
Drug Interactions
Reduce dosages of concurrent 1:
- Barbiturates
- Narcotics
- Other CNS depressants
- Neuromuscular blocking agents (risk of excessive block)
Practical Notes
- The 50% solution comes as 2 mL vials containing 1 g (500 mg/mL) 1
- Use 2 vials (4 mL total) for the 2 g dose
- No preservatives - discard unused portion 1
- Inspect visually before administration; do not use if particulate matter or discoloration present 1
The evidence for magnesium in COPD exacerbations remains mixed, with some studies showing benefit 2, 7 and others showing no effect 3, 8. However, when used as adjunctive therapy alongside standard bronchodilators and corticosteroids, the safety profile is acceptable with proper monitoring.